Lexaria Bioscience Corp. (LEXX)
1.00
+0.13
(+15.46%)
USD |
NASDAQ |
Apr 02, 14:43
Lexaria Bioscience Research and Development Expense (TTM) : 6.957M for Nov. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Oncolytics Biotech, Inc. | 9.547M |
| Aurinia Pharmaceuticals, Inc. | 32.50M |
| Edesa Biotech, Inc. | 3.774M |
| Xenon Pharmaceuticals, Inc. | 298.40M |
| ProMIS Neurosciences, Inc. | 33.38M |